Research progress on alternative non-classical mechanisms of PCSK9 in atherosclerosis in patients with and without diabetes

Tang, Y; Li, SL; Hu, JH; Sun, KJ; Liu, LL; Xu, DY

Xu, DY (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Internal Cardiovasc Med, 139 Middle Renmin Rd, Changsha 410011, Hunan, Peoples R China.

CARDIOVASCULAR DIABETOLOGY, 2020; 19 (1):

Abstract

The proprotein convertase subtilisin/kexin type 9 (PCSK9) acts via a canonical pathway to regulate circulating low-density lipoprotein-cholesterol (LD......

Full Text Link